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Abstract
The management of pain – despite many anaesthetic drugs – remains to be an urgent task. If 
the goal is to achieve permanent pain relief – and not to temporarily mask the pain (masking 
pathology) – then this goal can only be achieved by treating pain with physiotherapeutic 
methods, the most universal and effective of which, is low level laser therapy (LLLT).
The treatment methods vary fundamentally in the case of neuropathic (nonspecific, primary) 
pain, which includes pain with the localization of the trigger points (TP) and nociceptive 
(specific, secondary), which includes all types of pain resulting from trauma, inflammation, etc. 
When treating patients with fibromyalgia (FM), a comprehensive approach is required, using 
different methods of laser therapy and guided by well-known rules. These rules include setting 
all the correct parameters of the laser exposure (wavelength, operating mode, power, exposure, 
etc), limiting exposure and power to optimal values and limiting the total time of the procedure 
and the number of procedures per course.
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Introduction
Pain is a concept that is clinically and pathogenetically 
complex and heterogeneous. It differs in intensity, 
localization and subjective manifestations (shooting, 
pressing, pulsating, pricking, cutting, whining, etc) and 
can be permanent or periodic. All the existing varieties of 
the characteristics of pain are largely related to localization 
and what caused it. For pain management, an educated 
choice is made when administered appropriate medicines 
and effective treatment methods, particularly like laser 
therapy. To make these choices, it is essentially important to 
distinguish the two variants based on pathophysiological 
mechanisms: neuropathic (nonspecific, primary) and 
nociceptive (specific, secondary) pain.1, 2
A striking example of the widespread muscle or joint-
muscle pain is fibromyalgia (FM) - rheumatic disease 
of unclear etiology, characterized by generalized muscle 
weakness (a fatigue sensation) and painful palpations of 
characteristic areas of the body, considered to be tender 
points by some authors,3 and trigger points by others.4
According to studies about FM, around 6 million 
Americans suffer from it, while 4 million of them are 
women. Although there is no distinct pathophysiological 
basis of the disease, such patients are easily recognized 
by the characteristic prevalence and localization of 
pain in their bodies. Over long periods of observation, 
specialists came to the unequivocal conclusion that the 
treatment of patients with FM should be individual, and 
requires a holistic approach; they need time, empathy, 
and interaction with other professionals. Ensuring the 
effective management of these patients is often a real test 
of the professionalism of the physician.5 
It is necessary to discuss some of the words and terms 
used, which are extremely important in our case. Initially, 
the term tender points was used for FM,6 and trigger 
points for myofascial pain syndrome (MPS),7 all the 
while emphasizing the differences in the pathogenesis of 
the diseases themselves and the differences in the local 
painful areas.8,9 In recent years, however, the situation has 
changed, and most experts tend to the fact that the “points” 
defined by the Moscow International AIDS Foundation 
are virtually impossible to distinguish clinically or 
pathophysiologically from those characteristic of FM, and 
the disease itself represents the stages of a single process of 
chronic muscle pain.10 Therefore, it is logical to combine 
two variants of definition of points and call them “TP”, 
especially since the initial letters of word combinations 
are identical.
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But the most important thing is that the TP’s (tender points 
or trigger points) are the result of the nonspecific response 
of the central nervous system (CNS) in its interaction with 
the autonomic nervous system (ANS), which manifests 
itself in both FM and MPS. That is, the pain occurs in TP 
is neuropathic (nonspecific, primary), and explains the 
recommended integrated approach to solve the problem 
of the management of the pain syndrome in FM.
Sometimes, quite typically TP is confused with any 
local painful zone (PZ), when the pain induced by a 
pathological process (trauma, inflammation, etc), and has 
a nociceptive nature. Pathophysiological differences in 
the causes of 2 types of pain warrant two different types 
of approaches for its elimination. On the other hand, it 
is quite difficult to distinguish them, since there are no 
reliable objective methods of differentiation. Therefore, 
creates additional difficulties in the correct interpretation 
and systematization of scientific data.
Despite a significant number of drug and non-
pharmacological methods of treatment for patients with 
FM, their effectiveness is not good enough. In addition, 
long-term use of analgesics, sedatives and non-steroidal 
anti-inflammatory drugs (NSAIDs) - commonly used for 
treatment - lead to the development of side effects, the 
aggravation and the severity of the patients’ condition.11
Low-level laser therapy (LLLT) is the most universal 
therapeutic factor, which has no side effects or absolute 
contraindications, while unlike analgesics, it does not 
target only one link in the painful reception, but targets 
essentially the whole hierarchy of mechanisms of its 
origin and regulation.9
The use of the integrated approach, which involves a wide 
range of LLLT methods, allows restoring any abnormalities 
in the functioning of various organs and systems of the 
human body, which, in addition to directly blocking pain, 
ensures the elimination of the causes of the disease. This 
“universality” predetermines the exceptional effectiveness 
of LLLT in the reliable elimination of pain syndromes of 
different types, provided by varying the parameters of the 
techniques. Equally importantly, after a well-organized 
and methodized course of laser therapy, the healing effect 
persists for long periods of time, i.e. months and years. It 
is even possible to talk about this treatment in such a way 
that suggests the patient will forget out their pain, if not 
forever, then for a very long time.2,9 
In this article, we are not looking at the “analgesic” 
mechanisms of biomodulatory action (BA) of low-
intensity laser illumination (LLLI), however, a lot of work 
is devoted to this topic, we recommend you to read the 
latest published works on this issue.12,13 But it is necessary 
to note the fact that practically none of the works deal 
with “laser pain management”, considering one important 
circumstance - what type of pain, primary or secondary, 
i.e. they do not show the differences in the reasons of its 
occurrence when choosing the laser exposure technique. 
This is fundamentally important in this case. The 
methods of laser therapy are quite simple and absolutely 
safe. This follows directly from the known mechanisms 
of the LILI database, the illumination that causes the 
body’s response through the initiation of Ca2+-dependent 
processes at a cellular level, after which the disturbed 
homeostasis is restored through the development of the 
secondary response of various regulatory systems and 
organs, resulting in the patient’s recovery.14- 16 
However, it is necessary to understand that the safety and 
effectiveness of any method of treatment, including laser 
therapy, is achieved only if it is applied correctly. There 
are several common methods of laser therapy (methods 
of laser illumination).9,16
• external illumination; 
• projection of the internal organs;
• on immunocompetent organs;
• on large blood vessels: intravenous laser blood 
illumination (ILBI) and non-invasive laser blood 
illumination (NLBI);
• paravertebral;
• at the acupuncture points (AP);
• at trigger points (TP), painful points (PP) and painful 
areas (PA).
There are some very strict rules for the use of these 
techniques17:
• limiting of the exposure time,
• determination and use of the optimal power density 
(PD) and the wavelength of LLLT,
• preferred use of pulse mode, which is especially 
important for pain management, etc.
Unfortunately, in most works which use laser therapy as 
the main method of treatment for patients with FM and 
other pain syndromes, the parameters of the method are far 
from effective, so often the results are not impressive. The 
purpose of the review is to analyze various methodologies 
and methodological errors made by many researchers, 
and to develop recommendations based on the available 
scientific data, and to develop a correct understanding of 
the mechanisms of the LILI database and its own clinical 
experience.
We compiled a table with the most accurate indication 
of all parameters of the method of treatment of patients 
with FM, and in some pain syndromes, paying attention 
to those works in which the result was not obtained, while 
using the same parameters of the procedure (Table 1). We 
have maintained the authentic terminology in terms of 
diseases (FM and MPS).
Unlike other reviews, which mainly focus on the reliability 
of the obtained results (which is extremely important), 
the errors are analyzed below, and the pros and cons of 
each are listed, also it is suggested to more independently 
understand the various methods of influence.
Uncertainty in relation to TP (trigger points, tender points) 
and generally PZs, clear and unambiguous division of 
them, often leads to mistakes in the choice of tactics 
of treatment and methodology. In many works these 
Kisselev and Moskvin
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concepts are confused (Table 1). The lack of uniformity 
and a “standard” of terminology hinder the development 
of the methodology of treatment of patients with FM.
The table does not include the only experiment in which 
it was shown that the laser illumination of New Zealand 
rabbits (contact for 5 myofascial TP and muscle tension 
zones, 780 nm, continuous mode, 30 mW, 30 seconds 
(4.5 J/cm2) or 3 minutes (27 J/cm2, 5 consecutive days) 
affects some biochemical indicators associated with pain 
(β-endorphin, substance P, tumor necrosis factor TNF-α 
and cyclooxygenase-2). The conclusion is that the results 
depend on the energy density (ED), different biochemical 
parameters vary to different degrees with an increasing or 
decreasing ED.43 
However, in this work, one important fact was neglected, 
specifically, that the change in the ED was due to arithmetic 
actions (J/cm2) – in the case of exposure variation – 
nonlinearly affects the result (the effect), it is permissible 
to change only the power and area of influence of essential 
restrictions. In other words, with formally identical values 
of ED derived from different exposures, the effect can 
differ by mirror-image, and both the stimulation and 
inhibition of some process occur. This is one of the most 
common mistakes.
A majority of specialists only use the method of 
illuminating TP’s with lasers, which is not always 
effective. Indeed, it has been shown for a long time that 
the illumination of TP by a continuous LLLT of the 
red spectrum (633 nm) causes changes in sympathetic 
activity, accompanied by an increase of skin resistance at 
the site of exposure.44,45 The latency of peripheral sensory 
nerve fibers increases, which leads to a decline in the 
conduction velocity of the nerve impulse, and ultimately, 
to a decrease in pain.46 But this is not enough. 
In some studies, the role of metabolic shifts in the 
etiopathogenesis of FM, particularly energy processes are 
discussed. This aspect is considered from the position 
of the analysis of the mechanism of the onset of TP, for 
example, in tissue biopsies taken from these points, a 
decrease in the content of high-energy phosphates was 
detected47,48 as well as a change in phosphodiesterase 
activity.49 Data from the spectrographic study of muscles 
are evidence of local hypoxia.50 A study by Bochkova11 
showed that after the course of illumination therapy, 
with the presence of NSAIDs and antidepressants, 82% of 
patients had a normalization of the isoenzymatic spectrum 
of lactate dehydrogenase occur, which contributes to 
the improvement of energy supply to muscle tissue, 
the number of TP decreased and the morbidity of the 
surviving tissues reduced. This is a very important 
conclusion, objectively confirming the influence of LLLT 
on TP.
However, in addition to the pain syndrome typical for FM, 
a complex treatment with several RT methods is required, 
analysis of studies and independent clinical experience 
allows us to conclude that the effect of continuous LILI 
on TP is ineffective, it is necessary to use the pulsed mode 
and the infrared (IR) spectrum (duration of the light 
pulse 100-150 ns, pulsed power 10-15 W, wavelength 904 
nm).11, 51
If you analyse the publications on the topic, including 
those listed in Table 1, it can be seen that in the vast 
majority of cases, laser light is used in a continuous mode. 
In some cases, when using this option, one can get some 
effects, but it is not very pronounced, not prolonged and 
not always reliable, even though in Table 1 it shows that it 
is given positive results. Attempts to increase efficiency by 
increasing the power of laser light do not always help.23,25
It is known that when the frequency of pulsed lasers 
varies, the average power proportionally varies, which 
is actively used to vary the ED and allows optimizing 
the laser action. For different techniques, different 
frequencies (read, power) are optimal, but we repeat that 
this is true only for e LLLI-impulse. The work of Altan 
et al18 shows evidence in which the same modes are used 
for TP and also PZ, which are not related to the TP, and 
in both cases the frequency of 1000 Hz is not optimal. It 
would be correct to use LLLT with a varying frequency on 
TP, starting from 80 Hz (see below), when lighting the PZ, 
using frequencies above 3000 Hz for the first 1-2 sessions, 
then reducing to 80 Hz.
As we noted above, in the case of FM, the pain syndrome 
has its own peculiarities, which is the reason for using 
only complex laser therapy techniques, when various 
methods of action directed at different pathogenetic 
links are involved. One of the examples of the complex 
approach can be a technique in which the laser action of 
pulsed IR LLLT (890 nm) is performed in a transcranial 
manner on the TP and acupuncture points, and the pulse 
repetition rate is varied, which is extremely important in 
this case. 51
In the following, a little more about the frequencies for 
pulsed lasers are discussed. The first to suggest to vary 
the frequencies of pulsed infrared lasers was Liev et 
al,52 the essence of the technique is a gradual increase 
in the frequency from 80 Hz in the first procedure, 
to 3000 Hz in the 7th-8th procedures, then gradually 
reducing to 80 Hz by the 15th-16th procedures. Later, 
this technique was improved, and the limiting frequency 
was increased to 10 000 Hz (this makes it possible to use 
the laser therapeutic apparatus “LASMIK”).9,15 The logic 
of this approach is quite understandable to anyone who 
knows the basics of neurophysiology of pain and the 
mechanisms of LLLT. But the parameters of exposure to 
specific PZ’s, directly related to the focus of pathology, are 
fundamentally different, and not always unambiguous. In 
the management of pain, exposure is extremely important. 
Most Russian authors recommend exposures from 20 to 
60 seconds per one TP, for one procedure no more than 
10-12 points, for a course of at least 12-16 procedures.11,51 
In Table. 1 we see a rather wide range of exposures used 
in various studies, which is not always justified. When 
Kisselev and Moskvin
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exposed to specific PZ’s, exposure is optimal at 5 minutes 
per zone, possibly even two mins in case of multiple 
localization or additional use of other laser therapy 
methods during the procedure.
 Since the total time of the procedure cannot exceed 
20 minutes,17 this replacement (5 minutes instead of 
two minutes) is justified. The use of other exposures is 
not allowed in most cases (there are some exceptions). 
Violation of the rule “the procedure of laser therapy 
should not last more than 20 minutes” is the reason 
for the lack of results in a number of studies.24,42 In the 
management of pain, this is especially critical, since the 
maximum response of the CNS and ANS, including the 
nociceptive system, occurs exactly 20 minutes from the 
start of the procedure.
In one of the works (not included in Table 1), with the 
reference to Russian studies, the possibility of using 
VLOK-635 (wavelength 633-635 nm, power of 1-2 mW) is 
justified for the treatment of patients with fibromyalgia.53 
The authors motivate their choice by such well-known 
results of laser illumination as a normalization of 
the immune system, improvement of the rheological 
properties of blood and trophic provision of tissues.
Improvement of microcirculation and oxygen supply 
of various tissues after VLOK-635 is also closely related 
to the positive influence of LILI on the metabolism: the 
oxidation of energy materials - glucose, pyruvate, lactate 
– elevates.54 However, quite often (and very successfully) 
the intravenous version of the laser blood-clarification 
technique is replaced by a non-invasive (transcutaneous) 
method, using matrix red pulsed lasers (wavelength 635 
nm, pulse power 40 W with eight pieces of laser diodes 
arranged as four in 2 rows, an area of 8 cm2, a pulse 
duration of 100-150 ns, a frequency of 80-150 Hz).2,55
Thus, we can draw the following conclusions:
1. Methods of pain management are fundamentally 
different for neuropathic pain (nonspecific, primary), 
which includes pain with localization in TP, and 
nociceptive pain (specific, secondary), which includes all 
types of pain arising from trauma, inflammation, etc.
2. In the treatment of patients with FM, it is necessary to 
use only complex treatment, including the use of various 
methods of laser therapy.
3. It is necessary to be guided by some rules for carrying 
out laser therapy, in particular, to set all parameters of laser 
exposure (wavelength, operating mode, power, exposure, 
etc), limit exposure and power to optimal values, limit the 
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